Uncategorized

Thomas Dijkmans

Leiden, the Netherlands, January 30, 2019 – Charles River Laboratories International, Inc (NYSE: CRL) and Toxys have entered into an agreement to offer access to ToxTracker® in North America. ToxTracker is a suite of assays that allow rapid carcinogenicity toxicity hazard identification in novel and...

Paula van Rossum

5 July 2018 - ToxTracker is an in vitro assay that provides detailed insight into the mode-of-action of genotoxic compounds. The assay is generally performed in the absence and presence of a metabolising system. Metabolic activation of compounds is included following the industry standard by...

Paula van Rossum

Toxys has started a collaboration with Health Canada and the University of Swansea to implement the Quantitative Analysis tool PROAST for ToxTracker results. There is growing interest in quantitative analysis of in vitro genetic toxicity dose‐response data, and use of point‐of‐departure (PoD) metrics such as the...

Giel Hendriks

Our latest publication about the development and validation of the ToxTracker assay is now available online. The paper describes the different fluorescent reporter cell lines that ar used in ToxTracker to gain insight into the mechanism of genotoxicity of compounds. The ToxTracker assay is a...

Giel Hendriks

Just before the end of 2015, our most recent scientific description and validation of the ToxTracker technology got accepted for publication by the journal Toxicological Sciences.
The publication reports on the ToxTracker assay for mechanistic genotoxicity screening. By utilising a panel of reporter genes that are...

Giel Hendriks

Toxys recently joined the In Vitro Testing Industrial Platform (IVTIP). IVTIP is an informal platform that was founded in 1993 and currently comprises 42 companies from different sectors (assay developers, technology providers, chemical, pharmaceutical and cosmetics companies), with significant in vitro testing activities. Most of the...

Giel Hendriks

Today at the SME event from HollandBio, Toxys received the award for best business plan as part of the BioBusiness Masterclass. A jury of experts in Life Sciences acknowledged the strong technology and business opportunities at Toxys. The award is a great support for Toxys...

Sign up for our newsletter

Email Address

About Us

Toxys is a Dutch biotech company that provides innovative in vitro toxicity screening solutions to rapidly identify hazardous and potential carcinogenic properties of novel compounds during the early phases of product and drug development.